KERRY NATHAN: Open Payments
NPI 1003882242 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,877 in 237 payments from 32 companies in 2025. Trend: 2023 $3,213 · 2024 $3,770 · 2025 $4,877
Food & beverage: $4,252Consulting: $350Education: $275
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 19 | $667 |
| UCB, Inc. | 41 | $567 |
| Neurocrine BioSciences, Inc. | 32 | $564 |
| Avadel CNS Pharmaceuticals, LLC | 11 | $359 |
| Teva Pharmaceuticals USA, Inc. | 11 | $309 |
| Biogen, Inc. | 12 | $296 |
| Novartis Pharmaceuticals Corporation | 22 | $271 |
| HARMONY BIOSCIENCES LLC | 10 | $255 |
| ABBVIE INC. | 13 | $236 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $189 |
Products named: INGREZZA, XYWAV, LUMRYZ, KESIMPTA, WAKIX, VUMERITY, Fintepla, EPIDIOLEX.
Industry payments across MI — which companies pay providers there.
